PG vs VRTX · P/E 25, rev $84.28B vs P/E 30, rev $12.00B
Procter & Gamble Company (PG) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
PG currently screens at market cap $373.53B and trailing P/E 25.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the PG and VRTX stock pages for the full models.
Not investment advice.